We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes

This study is enrolling participants by invitation only.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01186276
First Posted: August 23, 2010
Last Update Posted: November 20, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Stanford University
  Purpose
This study will assess whether dietary fiber supplements can reduce the production of chemicals which are produced by colon bacteria and normally excreted from the body by the kidney, but build up in the body in patients on hemodialysis.

Condition Intervention
Kidney Failure, Chronic Dietary Supplement: Fiber Dietary Supplement: Corn starch

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Official Title: Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Plasma level of p-cresol sulfate [ Time Frame: 8 weeks ]

Secondary Outcome Measures:
  • Caloric intake [ Time Frame: 8 weeks ]

Estimated Enrollment: 50
Study Start Date: July 2010
Estimated Study Completion Date: December 2019
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Corn Starch
Corn starch will serve as the control arm.
Dietary Supplement: Corn starch
Corn starch to be consumed daily for 6 weeks. This will serve as the control/placebo arm.
Experimental: Fiber
Fiber will serve as the intervention.
Dietary Supplement: Fiber
Dietary fiber supplements to be consumed daily for 6 weeks.

Detailed Description:

The study procedures will consist of:

  • taking a dietary supplement containing either fiber or starch (starch serves as a control for fiber) for six weeks. The fiber dose initially employed will be 30 g/day of high amylose corn and the control starch dose employed will be 30 g/day of waxy corn starch. Supplements which come in dry powder form will be mixed in liquid or food for consumption.
  • filling out a food record and a quality of life questionnaire
  • keeping a diary of any gi symptoms
  • collecting samples of blood, spent dialysate, urine(if the patient still makes urine) and stool.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • stable dialysis patients able to provide consent.

Exclusion Criteria:-- known g.i. disease

  • use of antibiotics for the last two month or expected antibiotic use
  • recent hospitalization or other event resulting in instability of food intake
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01186276


Locations
United States, California
VA Palo Alto Health Care System
Palo Alto, California, United States, 94304
Satellite Dialysis
Redwood City, California, United States, 94063
SCVMC
San Jose, California, United States, 95128
Sponsors and Collaborators
Stanford University
National Institutes of Health (NIH)
Investigators
Principal Investigator: Timothy W Meyer Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01186276     History of Changes
Other Study ID Numbers: SU-07292010-6626
NIH R21AT005123-01A1
First Submitted: August 19, 2010
First Posted: August 23, 2010
Last Update Posted: November 20, 2014
Last Verified: November 2014

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Failure, Chronic
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic